Lorraine Christie Porter
Direktor/Vorstandsmitglied bei TCB Newco Ltd.
Profil
Lorraine Christie Porter was the founder of STATS Group Ltd., which was founded in 1998, where she held the title of Co-Managing Director.
Currently, she holds the position of Non-Executive Director at TCB Newco Ltd.
Aktive Positionen von Lorraine Christie Porter
| Unternehmen | Position | Beginn |
|---|---|---|
TCB Newco Ltd.
 TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Lorraine Christie Porter
| Unternehmen | Position | Ende |
|---|---|---|
STATS Group Ltd.
 STATS Group Ltd. Oilfield Services/EquipmentIndustrial Services STATS Group Ltd. engages in the provision of pipeline-related solutions. It offers pressurised pipeline isolation, hot tapping and plugging services to the global oil, gas and petrochemical industries. The company was founded by Peter Alexander Duguid in 1998 and is headquartered in Kintore, the United Kingdom. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
STATS Group Ltd.
STATS Group Ltd. Oilfield Services/EquipmentIndustrial Services STATS Group Ltd. engages in the provision of pipeline-related solutions. It offers pressurised pipeline isolation, hot tapping and plugging services to the global oil, gas and petrochemical industries. The company was founded by Peter Alexander Duguid in 1998 and is headquartered in Kintore, the United Kingdom. | Industrial Services |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | Health Technology |
